Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2017 16:35 ET | Source: Dynavax Technologies

Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B(TM)

BERKELEY, CA--(Marketwired - July 28, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological...
June 02, 2017 16:01 ET | Source: Dynavax Technologies

Dynavax Presents Updated Data for SD-101 in Combination with KEYTRUDA(R) (pembrolizumab) Highlighting an ORR in 7 out of 7 Patients Naive to an Anti-PD-1 or Anti-PD-L1 Therapy

BERKELEY, CA--(Marketwired - June 02, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced the presentation of findings in patients with metastatic melanoma in the dose escalation phase...
May 19, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax to Present Data on SD-101 in Combination with KEYTRUDA(R) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

BERKELEY, CA--(Marketwired - May 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that updated data from an ongoing Phase 1b/2 study investigating SD-101, Dynavax's...
May 08, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax Reports First Quarter 2017 Financial Results

BERKELEY, CA--(Marketwired - May 08, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2017. Cash, cash equivalents and...
April 03, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B

BERKELEY, CA--(Marketwired - April 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the U.S. Food and Drug Administration (FDA) has informed the company that the...
March 20, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American Association for Cancer Research Annual Meeting

BERKELEY, CA--(Marketwired - March 20, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will be presenting data on three programs based on stimulation of the immune...
March 13, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update

BERKELEY, CA--(Marketwired - March 13, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the fourth quarter and year ended December 31, 2016. The net loss...
March 06, 2017 08:00 ET | Source: Dynavax Technologies Corporation

Dynavax Presents Promising Clinical Data from Lead Immuno-Oncology Candidate, SD-101, at the International Congress on Targeted Anticancer Therapies

BERKELEY, CA--(Marketwired - March 06, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced the presentation of findings in patients with metastatic melanoma in the dose escalation phase...
March 02, 2017 06:00 ET | Source: Dynavax Technologies Corporation

Dynavax to Present at the Cowen and Company 37th Annual Health Care Conference

BERKELEY, CA--(Marketwired - March 02, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Eddie Gray, Dynavax's chief executive officer, will present at the Cowen and...
February 28, 2017 16:01 ET | Source: Dynavax Technologies Corporation

Dynavax Announces FDA Acceptance for Review of Its Complete Response to November 2016 CRL and PDUFA Action Date for HEPLISAV-B(TM)

BERKELEY, CA--(Marketwired - February 28, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Dynavax's...